Viatris Inc (VTRS)

12.45 +0.07 (+0.57%) USD  |  NASDAQ  |  Dec 31, 16:00
12.45 0.00 (0.00%) After-Hours: 20:00
More

Viatris Research and Development Expense (Annual): 805.20M for Dec. 31, 2023

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for VTRS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Lexicon Pharmaceuticals Inc 58.89M
Moderna Inc 4.845B
Baxter International Inc 667.00M
Boston Scientific Corp 1.414B
Insulet Corp 205.00M